特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
918556

歯科生体材料の世界市場:2020年~2024年

Dental Biomaterials Market by Product and Geography - Forecast and Analysis 2020-2024

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 150 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
歯科生体材料の世界市場:2020年~2024年
出版日: 2019年11月21日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 150 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の歯科用生体材料市場は、歯科疾患の増加、新製品の発売、M&A活動の増加などが成長促進要因となり、予測期間中に約7%のCAGRで拡大する見込みです。しかし、医療処置に関連する高コスト、開発途上国での代替品の存在と認識不足、および歯科骨移植の厳格な規制と合併症などの要因が、予測期間中の歯科生体材料産業の成長を妨げる可能性があります。

当レポートでは、世界の歯科生体材料市場について調査分析し、市場規模および成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

  • イントロダクション1
  • イントロダクション2
  • 米ドルの通貨換算レート

第3章 市場状況

  • 市場のエコシステム
  • 市場の特徴
  • バリューチェーン分析
  • 市場セグメンテーション分析

第4章 市場規模

  • 市場の定義
  • 市場規模(2019年)
  • 市場規模および予測(2019年~2024年)
  • 市場の見通し

第5章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市況

第6章 市場セグメンテーション:製品別

  • 市場セグメンテーション:製品別
  • 比較:製品市場規模および予測(2019年~2024年)
  • 骨移植
  • 膜および組織再生製品
  • 市場機会:製品別

第7章 顧客情勢

第8章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模および予測(2019年~2024年)
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 市場機会

第9章 意思決定の枠組み

第10章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第11章 市場動向

  • 戦略的提携の増加
  • 歯科用生体材料の技術的進歩とイノベーション

第12章 ベンダー情勢

  • 概要
  • 創造的破壊の状況
  • 競争シナリオ

第13章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Advanced Medical Solutions Group Plc
  • Biomatlante SA
  • DENTSPLY SIRONA Inc.
  • Envista Holdings Corp.
  • Geistlich Pharma AG
  • Henry Schein Inc.
  • Medtronic Plc
  • Straumann Holding AG
  • Tissue Regenix Group Plc
  • Zimmer Biomet Holdings Inc.

第14章 付録

  • 調査方法
  • 略語のリスト
  • ベンダーの市場ポジショニングの定義

第15章 TECHNAVIOについて

図表

LIST OF EXHIBITS:

  • Exhibit 01: Global healthcare supplies market
  • Exhibit 02: Segments of global healthcare supplies market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Product overview
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Product - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Bone grafts - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Bone grafts - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Membranes and tissue regeneration products - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Membranes and tissue regeneration products - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2019-2024 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 33: Population aged 65 years and above 2015 and 2018 (% of total population)
  • Exhibit 34: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 35: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 36: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 37: Key leading countries
  • Exhibit 38: Market opportunity
  • Exhibit 39: Product launch details
  • Exhibit 40: M&A and their market impact analysis
  • Exhibit 41: Impact of drivers and challenges
  • Exhibit 42: Types of strategic alliances
  • Exhibit 43: Vendor landscape
  • Exhibit 44: Landscape disruption
  • Exhibit 45: Vendors covered
  • Exhibit 46: Vendor classification
  • Exhibit 47: Market positioning of vendors
  • Exhibit 48: Advanced Medical Solutions Group Plc - Vendor overview
  • Exhibit 49: Advanced Medical Solutions Group Plc - Business segments
  • Exhibit 50: Advanced Medical Solutions Group Plc - Geographic focus
  • Exhibit 51: Advanced Medical Solutions Group Plc - Segment focus
  • Exhibit 52: Advanced Medical Solutions Group Plc - Key offerings
  • Exhibit 53: Advanced Medical Solutions Group Plc - Key customers
  • Exhibit 54: Biomatlante SA - Vendor overview
  • Exhibit 55: Biomatlante SA - Product segments
  • Exhibit 56: Biomatlante SA - Organizational developments
  • Exhibit 57: Biomatlante SA - Key offerings
  • Exhibit 58: Biomatlante SA - Key customers
  • Exhibit 59: DENTSPLY SIRONA Inc. - Vendor overview
  • Exhibit 60: DENTSPLY SIRONA Inc. - Business segments
  • Exhibit 61: DENTSPLY SIRONA Inc. - Organizational developments
  • Exhibit 62: DENTSPLY SIRONA Inc. - Geographic focus
  • Exhibit 63: DENTSPLY SIRONA Inc. - Segment focus
  • Exhibit 64: DENTSPLY SIRONA Inc. - Key offerings
  • Exhibit 65: DENTSPLY SIRONA Inc. - Key customers
  • Exhibit 66: Envista Holdings Corp. - Vendor overview
  • Exhibit 67: Envista Holdings Corp. - Business segments
  • Exhibit 68: Envista Holdings Corp. - Key offerings
  • Exhibit 69: Envista Holdings Corp. - Key customers
  • Exhibit 70: Geistlich Pharma AG - Vendor overview
  • Exhibit 71: Geistlich Pharma AG - Product segments
  • Exhibit 72: Geistlich Pharma AG - Organizational developments
  • Exhibit 73: Geistlich Pharma AG - Key offerings
  • Exhibit 74: Geistlich Pharma AG - Key customers
  • Exhibit 75: Henry Schein Inc. - Vendor overview
  • Exhibit 76: Henry Schein Inc. - Product segments
  • Exhibit 77: Henry Schein Inc. - Organizational developments
  • Exhibit 78: Henry Schein Inc. - Geographic focus
  • Exhibit 79: Henry Schein Inc. - Segment focus
  • Exhibit 80: Henry Schein Inc. - Key offerings
  • Exhibit 81: Henry Schein Inc. - Key customers
  • Exhibit 82: Medtronic Plc - Vendor overview
  • Exhibit 83: Medtronic Plc - Business segments
  • Exhibit 84: Medtronic Plc - Organizational developments
  • Exhibit 85: Medtronic Plc - Geographic focus
  • Exhibit 86: Medtronic Plc - Segment focus
  • Exhibit 87: Medtronic Plc - Key offerings
  • Exhibit 88: Medtronic Plc - Key customers
  • Exhibit 89: Straumann Holding AG - Vendor overview
  • Exhibit 90: Straumann Holding AG - Product segments
  • Exhibit 91: Straumann Holding AG - Organizational developments
  • Exhibit 92: Straumann Holding AG - Geographic focus
  • Exhibit 93: Straumann Holding AG - Segment focus
  • Exhibit 94: Straumann Holding AG - Key offerings
  • Exhibit 95: Straumann Holding AG - Key customers
  • Exhibit 96: Tissue Regenix Group Plc - Vendor overview
  • Exhibit 97: Tissue Regenix Group Plc - Product segments
  • Exhibit 98: Tissue Regenix Group Plc - Organizational developments
  • Exhibit 99: Tissue Regenix Group Plc - Geographic focus
  • Exhibit 100: Tissue Regenix Group Plc - Segment focus
  • Exhibit 101: Tissue Regenix Group Plc - Key offerings
  • Exhibit 102: Tissue Regenix Group Plc - Key customers
  • Exhibit 103: Zimmer Biomet Holdings Inc. - Vendor overview
  • Exhibit 104: Zimmer Biomet Holdings Inc. - Product segments
  • Exhibit 105: Zimmer Biomet Holdings Inc. - Organizational developments
  • Exhibit 106: Zimmer Biomet Holdings Inc. - Geographic focus
  • Exhibit 107: Zimmer Biomet Holdings Inc. - Segment focus
  • Exhibit 108: Zimmer Biomet Holdings Inc. - Key offerings
  • Exhibit 109: Zimmer Biomet Holdings Inc. - Key customers
  • Exhibit 110: Validation techniques employed for market sizing
  • Exhibit 111: Definition of market positioning of vendors
目次
Product Code: IRTNTR40190

About this market

Technavio's dental biomaterials market analysis considers sales from bone grafts and membranes and tissue regeneration products. Our study also finds the sales of dental biomaterials in Asia, Europe, North America, and ROW. In 2019, the bone grafts segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the launch of innovative grafts and technological advances will play a significant role in the bone grafts segment to maintain its market position. Also, our global dental biomaterials market report looks at factors such as the increasing prevalence of dental conditions, new product launches, and the growing number of M&A activities. However, high costs associated with medicinal procedures, presence of substitutes and lack of awareness in developing countries, and stringent regulations and complications with dental bone grafts may hamper the growth of the dental biomaterials industry over the forecast period.

Overview

Increasing prevalence of dental conditions

There is a growing prevalence of dental disorders such as tooth decay and periodontal diseases owing to changing food habits and lifestyles, consumption of tobacco, smoking, and poor oral health. The growth of the geriatric population has further increased the prevalence of periodontal diseases across the world. This has increased the demand for biomaterials for tissue engineering and several methods of regenerative periodontal therapies, such as the use of bone graft, barrier membrane, and combined procedures for the treatment of periodontal diseases. Thus, the increasing prevalence of dental conditions will lead to the expansion of the global dental biomaterials market at a CAGR of almost 7% during the forecast period.

Technological advances and innovations in dental biomaterials

Digital technology and diagnostic tools such as CAD/CAM, digitally assisted treatment planning for implant surgery/restorations, and caries diagnosis tools have shifted dentistry to a new level. The application of artificial intelligence (Al) is expected to have a significant impact on dental care, which will open a range of applications for dental biomaterials. New grafts and molecules with biomimetic and biological properties play a crucial role in the functional rehabilitation of bone defects. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global dental biomaterials market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of several major players, the global dental biomaterials market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading milk chocolate manufacturers, that include Advanced Medical Solutions Group Plc, Biomatlante SA, DENTSPLY SIRONA Inc., Envista Holdings Corp., Geistlich Pharma AG, Henry Schein Inc., Medtronic Plc, Straumann Holding AG, Tissue Regenix Group Plc, and Zimmer Biomet Holdings Inc.

Also, the dental biomaterials market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Value chain analysis
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Bone grafts - Market size and forecast 2019-2024
  • Membranes and tissue regeneration products -
  • Market size and forecast 2019-2024
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Growing number of strategic alliances
  • Technological advances and innovations in dental biomaterials

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Advanced Medical Solutions Group Plc
  • Biomatlante SA
  • DENTSPLY SIRONA Inc.
  • Envista Holdings Corp.
  • Geistlich Pharma AG
  • Henry Schein Inc.
  • Medtronic Plc
  • Straumann Holding AG
  • Tissue Regenix Group Plc
  • Zimmer Biomet Holdings Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.